To assess the associations among baseline levels of fasting insulin and proinsulin, proinsulin:insulin ratio, and the development of type 2 diabetes mellitus in apparently healthy middle-aged women.
In a nested case-control study involving a nationwide cohort of 27,628 participants from the Women’s Health Study, 126 women with diabetes diagnosed during a 4-year follow-up period were compared with 225 age-matched controls. Fasting insulin level and proinsulin:insulin ratio were assessed in quartiles, and proinsulin level was assessed in categories (≤4.0 pmol/L, 4.01 to 6.99 pmol/L, ≥7.0 pmol/L). The risk of developing type 2 diabetes was determined using conditional logistic regression analysis that adjusted for body mass index and other diabetes risk factors.
Baseline insulin and proinsulin levels and proinsulin:insulin ratios were significantly higher among cases than among controls. Women with elevated insulin levels in the highest as compared with the lowest quartile were more likely to develop diabetes (odds ratio [OR] = 5.6; 95% confidence interval [CI]: 1.8 to 17.6), as were women with elevated (≥7.0 pmol/L vs. ≤4.0 pmol/L) proinsulin levels (OR = 16.4; 95% CI: 5.8 to 46.8) and women with proinsulin:insulin ratios in the highest quartile (OR = 9.6; 95% CI: 3.1 to 30.8). Similar results were observed among women with a baseline hemoglobin A1c level ≤6.0%. In time-trend analyses, fasting insulin was a consistent predictor of long-term risk. Proinsulin and proinsulin:insulin ratio, although predictive throughout the study, were especially strong predictors of rapid progression to type 2 diabetes.
Elevated fasting insulin and proinsulin levels and proinsulin:insulin ratio are associated with an increased risk of developing type 2 diabetes in apparently healthy middle-aged women.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The natural history of impaired glucose tolerance in the Pima Indians.N Engl J Med. 1988; 319: 1500-1506
- A two-step model for development of non-insulin-dependent diabetes.Am J Med. 1991; 90: 229-235
- Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.Diabetes. 1990; 39: 283-298
- Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.Diabetes. 1995; 44: 1386-1391
- Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.Diabetologia. 1993; 36: 553-559
- Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.Diabetologia. 1995; 38: 1176-1182
- Proinsulin as a marker for the development of NIDDM in Japanese-American men.Diabetes. 1995; 44: 173-179
- A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance.Diabet Med. 1996; 13: 330-336
- Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance.Diabetologia. 1996; 39: 113-118
- Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM.Diabetologia. 1997; 40: 830-837
- Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.Diabetes. 2002; 51: 1263-1270
- Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.N Engl J Med. 2001; 344: 1343-1350
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.N Engl J Med. 2002; 346: 393-403
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet. 1998; 352: 837-853
- The Women’s Health Study.J Myocard Ischemia. 1992; 4: 27-29
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Diabetes Care. 1997; 20: 1183-1197
- Diabetes in America.Diabetes Care. 1998; 21(suppl): C11-C14
- Insulin assays and reference values.Diabetes Metab. 1999; 25: 459-476
- Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.Biochem J. 1989; 260: 535-541
- Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies.Clin Chem. 1993; 39: 2146-2150
- First direct assay for intact human proinsulin.Clin Chem. 1998; 44: 1514-1519
- How good a marker is insulin level for insulin resistance?.Am J Epidemiol. 1993; 137: 959-965
- Ability of alternative indices of insulin sensitivity to predict cardiovascular risk.Ann Epidemiol. 1998; 8: 358-369
- The homeostasis model in the San Antonio Heart Study.Diabetes Care. 1997; 20: 1087-1092
- Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?.Diabetes. 1989; 38: 1333-1336
- What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin- processing mechanism.Diabetes. 1994; 43: 511-517
- Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.Diabetes. 1997; 46: 1725-1732
- Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.J Clin Endocrinol Metab. 1999; 84: 2068-2074
- Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr.Diabetes. 1987; 36: 179-186
- Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.Ann Intern Med. 1990; 113: 909-915
- Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.Diabetes. 1994; 43: 1490-1493
- Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.Diabetes Care. 1998; 21: 127-133
- Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes.Diabet Med. 1990; 7: 407-413
- Risk factors for NIDDM in white population. Paris prospective study.Diabetes. 1991; 40: 796-799
- Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.BMJ. 1991; 303: 755-760
- Risk factors for the development of NIDDM in Yonchon County, Korea.Diabetes Care. 1997; 20: 1842-1846
- Fasting proinsulin concentrations predict the development of type 2 diabetes.Diabetes Care. 1999; 22: 262-270
Accepted: December 5, 2002
Received in revised form: November 20, 2002
Received: April 3, 2002
☆Supported by grants from the National Heart, Lung, and Blood Institute (HL43851, HL58755, and HL63293) and the National Cancer Institute (CA47988), Bethesda, Maryland. Dr. Ridker is supported by a Distinguished Clinical Scientist Development Award from the Doris Duke Foundation, New York, New York.
© 2003 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.